19 / 21
THE GEC ESTROHANDBOOKOF BRACHYTHERAPY | Part I: The Basics of Brachytherapy
Version 1 - 22/10/2015
Radiobiology of LDR, HDR, PDR and VLDR Brachytherapy
19
spective randomized trial comparing two BT low dose rates in cervical carci-
nomas.
Int J Radiat Oncol Biol Phys
1994; 29: 953-60.
48. Hall EJ, Bedford JS: Dose rate: its effect on the survival of HeLa cells irradiated
with gamma rays.
Radiat Res
1964; 22: 305-15.
49. Hammer J, Seewald DH, Track C,
et al.
Breast cancer: primary treatment with
external-beam radiation therapy and high-dose-rate iridium implantation.
50. Radiology 1994;193:573–7.Harms W, Krempien R, Hensley FW, Berns C,
Wannenmacher M, Fritz P. Results of chest wall reirradiation using pulsed-
dose-rate (PDR) BT molds for breast cancer local recurrences.
Int J Radiat
Oncol Biol Phys
2001; 49: 205-10.
51. Harms W, Krempien R, Hensley FW, Berns C, Fritz P, Wannenmacher M. 5
–year results of pulsed dose rate BT applied as a boost after breast-conserving
therapy in patients at high risk for local recurrence from breast cancer.
Strahl-
enther Onkol
2002; 178: 607-14
52. Harms W, Krempien R, Grehn C
et al
. Daytime pulsed dose rate BT as a new
treatment option for previouwly irradiated patients with recurrent oesopha-
geal cancer.
BJR
2005; 78: 236-241.
53. Haustermans K, Fowler J, Landuyt W,
et al
. Is pulsed dose rate more damaging
to spinal cord of rats than continuous low dose rate?
Radiother Oncol
1997; 45:
39-47.
54. Herstein, A.; Wallner, K.; Merrick, G.; Mitsuyama, H; Armstrong, J.; True, L.
Cavanagh, W. Butler, W.: I‐125 Versus Pd‐103 for Low‐Risk Prostate Cancer:
Long‐Term Morbidity Outcomes From a Prospective Randomized Multi-
center Controlled Trial.
Cancer Journal
: 2005 - 11 - 5 - 385–389
55. HopewellJW.,Nyman,J.Turesson,I. Time factor for acute tissue reactions
following fractionated irradiation: a balance between repopulation and en-
hanced radiosensitivity.
Int J Radiat Biol.
2003 Jul; 79(7):513-24.
56. Horiot JC, Pourquier H, Schraub S,
et al
. Current status of the management of
cancer of the cervix in daily practice and in clinical research. I, Mould RF (ed)
B
rachytherapy 2. Nucletron International. Leersum
1989 pp 199-214
57. Hoskin PJ, Rojas AM, Bownes PJ, Lowe GJ, Ostler PJ, Bryant L. Randomised
trial of external beam radiotherapy alone or combined with high-dose-rate
brachytherapy boost for localised prostate cancer.
RadiotherOncol.
2012; 103:
217-222
58. Hoskin P, Rojas A, Lowe G, Bryant L, Ostler P, Hughes R, Milner J, Cladd H
High-dose-rate brachytherapy alone for localized prostate cancer in patients
at moderate or high risk of biochemical recurrenceInt
J Radiat Oncol Biol
Phys.
2012 Mar 15;82(4):1376-84.
59. Hunter RD. Dose rate correction in LDR intracavitary therapy. In: Mould RF,
Battermann JJ, editors. BT. From radium to optimization.
Nucletron Interna-
tional
1994. BV. Veenendaal. The Netherlands.
60. Inoue T, Inoue T, Teshima T, Murayam S,
et al
. Phase III trial of high and low
dose rate interstitial radiotherapy for early oral tongue cancer.
Int J Radiat
Oncol Biol Phys
1996; 36: 1201-6.
61. Inoue T, Inoue T, Yamazaki H,
et al
. High dose rate versus low dose rate inter-
stitial radiotherapy for carcinoma of the floor of mouth.
Int J Radiat Oncol Biol
Phys
1998; 41: 53-8.
62. International Commission on Radiation Units and Measurements. Dose and
volume specification for reporting intracavitary therapy in gynecology.
Re-
port 38 1985; Bethesda.
63. ICRU Report 50. Prescribing Recording, and Reporting Photon Beam Thera-
py. International Commission on Radiation Units and Measurements (1993).
7910 Woodmont Avenue, Bethesda, MD 20814, USA.
64. ICRU Report 62. Prescribing Recording, and Reporting Photon Beam Thera-
py (supplement to ICRU Report 50). International Commission on Radiation
Units and Measurements (1999). 7910 Woodmont Avenue, Bethesda, MD
20814, USA.
65. ICRU Report 83. Prescribing Recording, and Reporting Photon-Beam Inten-
sity-Modulated Radiation therapy (IMRT) (2010). 7910 Woodmont Avenue,
Bethesda, MD 20814, USA
66. ICRU report 88 Prescribing Recording, and Reporting Brachytherapy for can-
cer of the Cervix (2015). 7910 Woodmont Avenue, Bethesda, MD 20814, USA
67. Johansson B, Karlsson L, Liljegren G, Hardell L, Persliden J. Pulsed dose rate
BT as the sole adjuvant radiotherapy after breast –conserving surgery of T1-
T2 breast cancer: First long time results from a clinical study.
Radiother Oncol
2009; 90: 30-35.
68. Johansson B, Karlsson L, Reizenstein R, von Beckerath M Hardell L, Persliden
J. Pulsed dose rate brachytherapy as the boost in combination with external
beam irradiation in base of tongue cancer. Long term results from a uniform
clinical series.
J. of Contemp Brachyther
;2011: 3,1. 11-17)
69. Joiner M 2009 Quantifying cell kill and cell survival in
Basic Clinical Radiobi-
ology.
4th Edition. Hodder Arnold 2009 pp41-55
70. Joinerr M, van der Kogel A Steel G. Introduction:the significance of radiobi-
ology and radiotherapy for cancer treatment
Basic Clinical Radiobiology.
4th
Edition. Hodderrnold 2009 pp1-10
71. King CR. What is the T-pot for prostate cancer? Radiobiological implications
of the equivalent outcome with I
-125
or Palladium
-103
.
Int J Radiat Oncol Biol
Phys
2000; 47(5) 1165-1167
72. Kirkpatrick JP,Meyer JJ, Marks LB. The Linear-quadratic model is inappro-
priate to model high doses per fraction effects in radiosurgery.
Seminars in
Radiation Oncology
2008; 18: 240-243
73. Kovacs G,,Galalea R, Loch T, Bertermann H, Kohr P, Schneider R, Kiming B.
Prostate presevation by combined external beam and HDR brachytherapy in
node negative prostate cancer.
Strahlenther
.
Onkol
. 1999: 175 S2 87-8
74. Kutcher GJ, Burman C. Calculation of complication probability factors for
non-uniform normal tissue irradiation: the effective volume method.
Int J Ra-
diat Oncol Biol Phys.
1989 Jun; 16(6):1623-30.
75. Larra F, Dixon B, Couette JE,
et al
. Facteur temps en curiethérapie ;
J Radiol
Electrol 1
977; 58: 329-33.
76. Lau HY, Hay JH, Flores AD, Threlfall WJ. Seven fractions of twice daily high
dose-rate BT for node-negative carcinoma of the mobile tongue results in loss
of therapeutic ratio.
Radiother Oncol
1996; 39: 15-8.
77. Leborgne F, Fowler JF, Leborgne JH,
et al
. Fractionation in medium dose rate
BT of cancer of the cervix.
Int J Radiat Oncol Biol Phys
1996; 35: 907-14.
78. Leborgne F, Fowler JF, Leborgne JH,
et al
. Medium-dose-rate BT of cancer of
the cervix: preliminary results of a prospectively designed schedule based on
the linear-quadratic model.
Int J Radiat Oncol Biol Phys
1999; 43: 1061-4.
79. Leung T-W, Wong V Y-W, Kwan K-H, Ng T Y, Wong C M, Tung SY, Leung
L.C. High dose rate brachytherapy for early stage oral tongue cancer
. Head &
Neck 20
02: 24(1) 274-281
80. Levendag PC, Schmitz PI, Jansen PP, Senan S, Eijkenboom WM, Sipkema D,
Meeuwis CA Kolkman-Deurloo IK Visser AG. Fractionated high-dose rate
and pulsed-dose rate BT: First clinical experience in squamous cell carcinoma
of the tonsillar fossa and hard palate.
Int J Radiat Oncol Biol Phys
1997; 38:
497-506.
81. Ling CC, Spiro IJ, Mitchell J, Stickler BA. The variation of OER with dose rate.
Int J Radiat Oncol Biol Phys
1985; 11: 1367-73.
82. Ling CC, Li WX, Anderson LL. The relative effectiveness of I
-125
and PD
-103
.
Int
J Radiat Oncol Biol Phys
2000 12 (2): 373-378.
83. Mansfield C.M, Komarnicky L.T, Schwartz G.F, Rosenberg A, Krishnan L,
Jewil W l,
et al
.Ten year results in 1070 patients with stages I and II breast
cancer treated by conservative surgeryand radiation therapy.
Cancer
, 1995: 75.
2328–2336
84. Marks LB Use of normal tissue complication probability models in the clinic.”
Int J Radiat Oncol Biol Phys
. 2010; 76(3 Suppl):S10-9.)
85. Martinez AA, Gonzalez J, Ye H
et al
. Dose escalation improves cancer related
events at 10 years for intermediate and high risk prostate cancer patients treat-
ed with hypofractionated high dose rate boost and external beam radiothera-
py.
Int J RadiatOncolBiolPhys
2011; 79: 363-370
86. Mason KA, Thames HD, Ochran TG,
et al.
Comparison of continuous and
pulsed low dose rate BT: biological equivalence in vivo.
Int J Radiat Oncol Biol
Phys
1994; 28: 667-71.
87. Mazeron JJ, Simon JM, Crook J,
et al
. Influence of dose rate on local control of
breast carcinomas treated by external beam irradiation plus iridium 192.
Int J
Radiat Oncol Biol Phys
1991; 21: 1173-77.
88. Mazeron JJ, Simon JM, Le Péchoux C,
et al
. Effect of dose rate on local control
and complications in definitive irradiation of T1-2 squamous cell carcinomas
of mobile tongue andfloor of mouth with interstitial 192.
Radiother Oncol
1991; 21: 39-47.